STAR

Strides Pharma Sci Ltd · ISIN INE939A01011 · Health Technology

Margin Trading Facility book for STAR across NSE and BSE. Free to use — no signup, no paywall. All figures in ₹ crore, derived from NSE and BSE public disclosures.

Funded value
₹57 Cr
as of 27 Apr 2026
Rank in book
#473
275 days tracked
Share of book
0.05%
of the whole NSE + BSE book
Peak funded
₹132 Cr
on 03 Mar 2025
NSE
₹56 Cr
BSE
₹0 Cr
Largest single-day addition
+₹21 Cr
on 11 Feb 2025
Largest single-day unwind
−₹28 Cr
on 12 Mar 2025

STAR — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole market book, and rank. Newest first.
DateCombinedDay ΔNSEBSE% of bookRank
27 Apr 2026₹57 Cr+₹3₹56₹00.05%473
13 Apr 2026₹54 Cr−₹3₹53₹00.05%464
10 Apr 2026₹57 Cr−₹1₹57₹00.05%449
09 Apr 2026₹58 Cr+₹1₹58₹00.05%442
08 Apr 2026₹57 Cr+₹2₹57₹00.05%450
07 Apr 2026₹55 Cr−₹0₹55₹00.05%462
06 Apr 2026₹55 Cr−₹1₹55₹00.05%460
02 Apr 2026₹56 Cr−₹0₹56₹00.05%449
01 Apr 2026₹57 Cr−₹1₹56₹00.05%450
30 Mar 2026₹57 Cr−₹1₹57₹00.05%442
27 Mar 2026₹58 Cr−₹0₹58₹00.05%445
25 Mar 2026₹58 Cr+₹0₹58₹00.05%441
24 Mar 2026₹58 Cr−₹0₹58₹00.05%448
23 Mar 2026₹58 Cr−₹0₹58₹00.05%451
20 Mar 2026₹59 Cr−₹0₹58₹00.05%455
19 Mar 2026₹59 Cr+₹0₹59₹00.05%452
18 Mar 2026₹59 Cr−₹2₹59₹00.05%446
17 Mar 2026₹61 Cr+₹0₹61₹00.05%429
16 Mar 2026₹60 Cr−₹0₹60₹00.05%432
13 Mar 2026₹61 Cr−₹3₹60₹00.05%438
12 Mar 2026₹64 Cr−₹2₹62₹20.06%422
11 Mar 2026₹66 Cr−₹1₹64₹20.06%414
10 Mar 2026₹67 Cr+₹0₹65₹20.06%409
09 Mar 2026₹67 Cr−₹1₹65₹20.06%406
06 Mar 2026₹68 Cr−₹0₹66₹20.06%405
05 Mar 2026₹68 Cr−₹0₹66₹20.06%403
04 Mar 2026₹68 Cr−₹0₹66₹20.06%403
02 Mar 2026₹68 Cr−₹1₹66₹20.06%405
27 Feb 2026₹70 Cr+₹1₹68₹20.06%404
26 Feb 2026₹69 Cr₹67₹20.06%406

IndiaMTF is an independent informational project. It is not a brokerage, is not affiliated with NSE, BSE or any SEBI-registered entity, and does not provide investment advice. Figures are derived from NSE and BSE public disclosures and may be revised or restated by the exchanges. Verify against the primary source before acting on anything here.